cyc 202 has been researched along with Experimental Mammary Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akli, S; Bui, T; Keyomarsi, K; Meijer, L; Van Pelt, CS | 1 |
1 other study(ies) available for cyc 202 and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Cdk2 is required for breast cancer mediated by the low-molecular-weight isoform of cyclin E.
Topics: Animals; Cell Transformation, Neoplastic; Cyclin E; Cyclin-Dependent Kinase 2; Female; Gene Silencing; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Knockout; Protein Isoforms; Protein Kinase Inhibitors; Purines; Roscovitine | 2011 |